Transvaginal Treatment of Symptomatic Cystocele Grade II-III

Inclusion Criteria: * Patient is a woman * Patient is between 40 and 90 years old * Patient has to sign the informed consent form prior to the procedure * Patient has to agree with the scheduled follow-up visits on month 1, month 6, year 1, year 2 and year 3 * Patient has symptomatic anterior prolapse Exclusion Criteria: * Recurrence cystocele * Patient is pregnant * Patient has a wish to become pregnant * Patient is taking Plavix, Sintrom, Marcoumar, Marevan, Brilique, Efient, Ticlid, Xarelto, Eliquis or Pradaxa. If intake is stopped prior to procedure, patient is allowed to be included. * Patient is taking LMWH in a dose of more than 40 mg/day * Patient has a life expectancy \< 1 year * Patient has a known connective tissue disease * Patient has a history of surgery of the anterior vaginal wall or pelvis * A scheduled hysterectomy during the index-procedure